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1  |  INTRODUC TION: GENER ATING 
SUBSETS OF MURINE γδ  T  CELL S
The biology of γδ T cells has been extensively studied in mouse mod-
els, on which we will focus this review. Such studies have shown 
that while γδ T cells develop alongside αβ T cells in the thymus, upon 
thymic egress most γδ T cells atypically localize to non-lymphoid pe-
ripheral tissues, where they can comprise up to 50% of all T cells. 
In the mouse, the tissue localization of γδ T cells segregates with 
surface expression of specific T cell receptor (TCR) γ chains. Early 
work on the genetics of TCR rearrangement during fetal, neonatal 
and adult thymocyte development revealed an organized and se-
quential rearrangement of specific Vγ-gene segments in developing 
γδ T cells during ontogeny. This ordered rearrangement results in 
timed production of defined γδ T cell populations, which leave the 
thymus and populate different epithelial-rich tissues in the adult an-
imal (reviewed in 1). Interestingly, the timely controlled pattern of 
Vγ chain expression during ontogeny recapitulates the order of Vγ 
Received: 19 June 2020  | Revised: 7 August 2020  | Accepted: 10 August 2020
DOI: 10.1111/imr.12918  
I N V I T E D  R E V I E W
From thymus to periphery: Molecular basis of effector γδ-T cell 
differentiation
Gina J. Fiala1  |   Anita Q. Gomes1,2  |   Bruno Silva-Santos1
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, 
provided the original work is properly cited.
© 2020 The Authors. Immunological Reviews published by John Wiley & Sons Ltd
Gina J. Fiala and Anita Q. Gomes are contributed equally to this work. 
This article is part of a series of reviews covering γδ T cells appearing in Volume 298 of Immunological Reviews 
1Instituto de Medicina Molecular João 
Lobo Antunes, Faculdade de Medicina, 
Universidade de Lisboa, Lisbon, Portugal
2H&TRC Health & Technology Research 
Center, ESTeSL—Escola Superior de 
Tecnologia da Saúde, Instituto Politécnico 
de Lisboa, Lisbon, Portugal
Correspondence
Bruno Silva-Santos, Instituto de Medicina 
Molecular João Lobo Antunes, Faculdade 




H2020 European Research Council, Grant/
Award Number: CoG_676401; European 
Commission Marie Sklodowska-Curie 
Individual Fellowship, Grant/Award 
Number: 752932
Abstract
The contributions of γδ T cells to immune (patho)physiology in many pre-clinical 
mouse models have been associated with their rapid and abundant provision of two 
critical cytokines, interferon-γ (IFN-γ) and interleukin-17A (IL-17). These are typically 
produced by distinct effector γδ T cell subsets that can be segregated on the basis of 
surface expression levels of receptors such as CD27, CD44 or CD45RB, among oth-
ers. Unlike conventional T cells that egress the thymus as naïve lymphocytes awaiting 
further differentiation upon activation, a large fraction of murine γδ T cells commits 
to either IFN-γ or IL-17 expression during thymic development. However, extrathymic 
signals can both regulate pre-programmed γδ T cells; and induce peripheral differ-
entiation of naïve γδ T cells into effectors. Here we review the key cellular events 
of “developmental pre-programming” in the mouse thymus; and the molecular basis 
for effector function maintenance vs plasticity in the periphery. We highlight some 
of our contributions towards elucidating the role of T cell receptor, co-receptors (like 
CD27 and CD28) and cytokine signals (such as IL-1β and IL-23) in these processes, 
and the various levels of gene regulation involved, from the chromatin landscape to 
microRNA-based post-transcriptional control of γδ T cell functional plasticity.
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organization at the Cγ1-TCRγ locus and proceeds from 3’-located Vγ5 
to 5’-located Vγ42 (mouse Vγ gene nomenclature of 3).
The first T cells produced in the fetal thymus are dendritic epi-
dermal T cells (DETC), a specialized subset of γδ T cells expressing 
an invariant Vγ5Vδ1 TCR. Subsequently, Vγ6+ γδ T cells are gener-
ated.4,5 Both DETC and Vγ6+ γδ T cells develop exclusively in the 
fetal thymus and have no junctional diversity due to absence of ter-
minal deoxynucleotidyl transferase expression. DETC are found in 
the adult skin, while Vγ6+ γδ T cells localize to diverse tissues such 
as, eg, uterine epithelia, tongue and meninges.6-8 Importantly, gen-
eration of DETC and Vγ6+ γδ T cells is restricted to the confined 
window of fetal development and cannot be induced in adult ani-
mals.9,10 Similarly, a subset of NKTγδ T cells expressing a Vγ1Vδ6 TCR 
is mainly produced in the perinatal phase.11 Other Vγ1+ and Vγ4+ γδ 
T cells develop from late fetal life onwards, throughout adulthood. 
These show higher junctional diversity and localize to diverse sites 
including peripheral lymphoid tissues, where they represent the ma-
jority of γδ T cells in the adult mouse. The distinctive developmental 
phases, orchestration of TCR rearrangements and specialized tissue 
localization suggest a diversity of physiological roles for γδ T cells 
encompassing features of both innate and adaptive – or “adaptate” – 
immune surveillance.12
The participation of γδ T cells in immune responses through pro-
duction of IFN-γ has long been established, and linked to beneficial 
roles in many cancer settings (reviewed in 13), as well as in viral, 
parasitic and intracellular bacterial infections, such as Listeria mono-
cytogenes.14,15 By contrast, γδ T cells producing IL-17 (γδ17 T cells) 
were identified more recently in mice as required for IL-17-mediated 
neutrophil recruitment during the early immune response to E coli 
infection.16,17 Since then, γδ17 T cells have been described in diverse 
tissues as playing either beneficial roles in host defense against 
Staphylococcus aureus and Candida albicans, among other infections, 
or detrimental roles in inflammatory diseases and in cancer, where 
they can promote angiogenesis, immune suppression and tumor cell 
growth (reviewed in 13,18,19).
The importance of γδ T cell functions mediated by IFN-γ and 
IL-17 has moved the field towards acknowledging two main effector 
γδ T cell subsets (Figure 1):
1. IFN-γ-producing (γδIFN) T cells, including a fetal/ perinatal-de-
rived subgroup expressing invariant and semi-invariant TCRs 
with no junctional diversity, which is made up by Vγ5+ DETC 
(in the skin) and the majority of Vδ6.1/Vδ6.3+ γδNKT cells 
(liver and spleen); and post-natally generated cells expressing 
more polyclonal TCRγδ (mostly Vγ1+ or Vγ4+) with junctional 
diversity (localized in lymphoid tissues).
2. γδ17 T cells usually expressing Vγ6+ or Vγ4+ TCRs, although 
minor populations expressing Vγ1 and Vγ2/3 chains have been 
described in the thymus and most notably in the liver.20,21 Vγ6+ 
γδ17 T cells are dominated by one invariant Vγ6Vδ1 clone lacking 
additional N-nucleotide insertions and few semi-invariant Vγ6Vδ1 
clones,7,22-24 whereas Vγ4+ γδ17 T cells present a more oligoclonal 
population encompassing multiple (semi)invariant TCRs.22,25
In this review, we will focus on the biology of effector γδ T cells 
making IFNγ or IL-17, from their early steps of differentiation in the 
thymus to their functional properties in the periphery, and the un-
derlying molecular mechanisms.
2  |  QUEST FOR SURFACE MARKERS FOR 
MOUSE γδ  T  CELL EFFEC TOR SUBSETS
Over the last decade or so, the field has put much effort into es-
tablishing markers to identify and analyze the two main effector γδ 
T cell subsets. The initial description of γδ17 T cells characterized 
F I G U R E  1  Thymic development of γδ T cells throughout mouse ontogeny. Limited windows in time allow for the generation of specific 
γδ T cell subsets in the murine thymus. γδ T cell development starts during early fetal and continues throughout life. The combination of 
distinct progenitors and a changing thymic microenvironment, constrains γδ T cell development during ontogeny. γδ T cells undergo effector 
cell differentiation inside the thymus influenced by signals received through the TCR. Strong TCR signaling promotes the IFNγ effector 
program, while IL-17-producing γδ T cells develop upon no/weak TCR signals. The dynamic changes of γδ T cell development are further 
reflected in specific patterns of TCRγ chain rearrangement and expression
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them as CD3highCD4−CD8−CD45RBlowCD44highCD62Llow, implicat-
ing a memory-like phenotype.16 It was therefore unexpected that 
peripheral γδ17 T cells did not express the IL-2 and IL-15 receptor 
common β chain (CD122) but the IL-2Rα chain (CD25).26 By contrast, 
CD122 expression on γδ T cells correlated well with IFNγ production 
and thus became a marker for IFNγ-producing γδ T cells (γδIFN T 
cells),26 later consolidated by Chien and colleagues.27 While CD122 
and CD25 associated well with effector fates in the peritoneal cav-
ity, it soon became clear that most γδ T cells in other tissues did 
not express either CD122 or CD25, although they produced consid-
erable amounts of IFNγ or IL-17 upon stimulation. By studying the 
tumor necrosis factor (TNF) receptor "superfamily" member CD27, 
our group described a robust marker differentially expressed on ef-
fector γδ T cell subsets in multiple tissues.28
CD27 had been previously used to characterize functional sub-
sets of αβ T cells and natural killer (NK) cells.29-31 Among γδ T cells, 
in most tissues, CD27 was expressed by 70%-90% of the cells, while 
10%-30% were CD27− in the steady state. We found that CD27− γδ 
T cells were CD44highCD62Llow and contained all IL-17 producers 
but very few γδIFN T cells. In contrast, CD27+ γδ T encompassed 
most CD122+ γδ T cells, had lower expression of CD44 and produced 
IFNγ but essentially no IL-17.28 Importantly, CD27 segregated two 
stable subsets in naïve mice, which retained their cytokine produc-
tion characteristics upon in vitro culture and exposure to cytokines 
implicated in αβ T cell polarization, or upon adoptive transfer into 
lymphopenic recipients, even upon infection with malaria parasites 
(Plasmodium berghei). Most interestingly, we found that the effector 
phenotypes were already established during thymic development, 
and since embryonic life. Our detailed analysis of γδ T cell develop-
ment revealed that manipulating CD70-CD27 signals on developing 
γδ T cells in fetal thymic organ cultures (FTOC) impacted effector 
phenotype acquisition. In particular, CD27 signals were required for 
expression of the lymphotoxin-β receptor (LTβR) and downstream 
genes previously associated with IFNγ production in γδ T cells.32 
Consistent with this, CD27-deficient mice showed a specific reduc-
tion in IFNγ (but not IL-17) producers. Therefore, we established 
CD27 not only as a useful marker, but also a key regulator of γδ T 
cell functional differentiation.28 Similarly, Ly-6C expression was de-
scribed to subdivide effector γδ T cells, with γδIFN cells being Ly-6C+ 
while γδ17 cells are exclusively Ly-6C−.33 By comparing γδ T cells, 
based on CD44 and Ly-6C expression, with CD8+ αβ T cells, the au-
thors suggested γδ T cell naïve-like and memory-like subsets sharing 
characteristics with adaptive αβ T cells.33 Of note, the downregula-
tion of CD27 has been documented when naïve γδ T cells encoun-
tered cognate antigen and underwent peripheral differentiation34 
similarly to what has been reported for human antigen-experienced/ 
memory γδ T cells.35,36
Besides lacking CD27 expression, γδ17 T cells were found to ex-
press SCART1 and SCART2 and CCR6 in the adult mouse.37,38 CCR6 
is the receptor for CCL20, a chemokine expressed upon microbial 
exposure, which has been reported to regulate lymphocyte migra-
tion towards sites of inflammation. The enrichment of γδ17 T cells 
among CCR6+ γδ T cells in the adult thymus and peripheral tissues 
was especially prominent and resulted in establishment of CCR6 as 
a γδ17 T cell marker. Of note, in the neonatal thymus only Vγ6+ γδ17 
thymocytes express CCR6, whereas the vast majority of Vγ4+ γδ17 
thymocytes do not; it was suggested that CCR6 expression might 
be induced extrathymically on dermal Vγ4+ γδ T cells.39 A detailed 
analysis of surface marker expression on γδ T cells in the neona-
tal thymus found that CCR6 was exclusively expressed on mature 
(CD24−) γδ T thymocytes.20 In the neonate, CD24− Vγ4+ γδ T cells are 
mostly absent from the thymus. Therefore, it remains possible that 
CCR6 induction occurs intrathymically on Vγ4+ cells that promptly 
leave to peripheral sites. Interestingly, the expression of the two 
scavenger receptors SCART1 and SCART2 was shown to be mutual 
exclusive on Vγ6+ and Vγ4+ dermal γδ17 T cells, respectively, pos-
sibly due to different ontogenic origins.40 More recently, the com-
bined use of CD24, CD44 and CD45RB allowed Pennington and 
colleagues to clearly identify the IFNγ (CD24−CD44highCD45RB+) 
and IL-17 (CD24−CD44highCD45RB-) committed subsets, as well as 
their developmental trajectories from immature (CD25+CD24+) γδ 
thymocytes.20 We find this phenotypic characterization of γδ T cells 
especially helpful (Figure 2).
Different thymic trajectories for the generation of γδIFN cells 
have been recently described by introducing transient surface mark-
ers, namely CD117, CD200 and CD371, as useful tools to segregate 
CD24+ γδ T cells within the adult thymus.41 CD371 identified the 
most immature γδ T cells; in the absence of TCR ligation during devel-
opment, these cells matured to naïve (γδTn) cells with a gene expres-
sion profile similar to γδ17 cells, and were exported to the periphery 
still expressing CD24. In contrast, TCR ligation induced expression 
of CD200 and biased development towards γδIFN, with an interme-
diate stage marked by CD117 expression.41 This study emphasized 
the thymic export of CD24+ γδ T cells in adult mice; and confirmed 
that CD24− γδ T cells in the adult thymus mostly represent long-lived 
resident effector cells generated during fetal/ perinatal life.
F I G U R E  2  Expression status of cell surface receptors that 
segregate effector γδ T cell subsets. IL-17+and IFNγ+γδ T cell 
subsets express different surface receptors enabling their 
identification and isolation based on these markers. The most 
commonly used markers are highlighted for IL-17+γδ T (blue) and 
IFNγ+γδ T cells (red). Noted within brackets are surface markers 
expressed on particular subpopulations of the respective effector 
subsets
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3  |  THYMIC γδ  T  CELL DE VELOPMENT: 
PRE-PROGR AMMING EFFEC TOR 
FUNC TIONS
3.1  |  TCRγδ signaling – a driving force in effector 
cell commitment?
Among the surface markers that segregate the two γδ T cell effec-
tor subsets (described above; Figure 2), we encounter several pro-
teins known as activation or maturation markers on conventional αβ 
T cells. In αβ T cells, activation markers are typically linked to TCR 
stimulation. Could the signal (strength) transmitted by the TCRγδ de-
termine the acquisition of effector fate in γδ thymocytes?
A major difficulty in γδ T cell research has been the limited 
knowledge on specific TCRγδ ligands. Therefore, most of the early 
studies analyzing the impact of TCR signaling were carried out using 
TCR transgenic mice with known specificities, which did not allow to 
enquire the full γδ T cell repertoire and its TCR(Vγ)-based subsetting 
described above. The synthesis of T10/T22-tetramers (two closely 
related β2-mircoglobulin-associated nonclassical MHC class I mole-
cules) for flow cytometry analysis enabled the first study of a minor 
but antigen-specific γδ T cell subset within wildtype (ie non-trans-
genic) mice.42 The analysis of T10/T22-specific γδ T cells in wildtype 
and β2-microglobulin-deficient mice found that these γδ T cells de-
veloped in both mice and, consequently, antigen encounter was nei-
ther required nor inhibitory for their generation.27 Interestingly, the 
expression of maturation markers on T10/T22-specific γδ T cells was 
affected in β2-microglobulin-deficient mice. While T10/T22-specific 
γδ T cells in wildtype mice included cells expressing high levels of 
CD122 and were enriched for IFNγ producers, this subset was not 
detected in T10/T22-specific γδ T cells of β2-microglobulin-deficient 
mice. Both mouse strains developed CD122low T10/T22-tetramer-
specific γδ T cells which produced predominantly IL-17. Therefore, 
this study suggested that γδ17 T cell commitment was indepen-
dent of ligand encounter during development, whereas the IFNγ-
producing fate required TCR engagement in the thymus.27
A subsequent study from our laboratory has provided additional 
data supporting a role of TCR signaling in the development of spe-
cific γδ T cell effector subsets. The research was based on a new 
mouse model, haploinsufficient for both CD3γ and CD3δ (termed 
CD3DH, for CD3 double haploinsufficiency), where we found both 
TCRγδ surface expression and TCRγδ signal strength to be substan-
tially reduced.43 Consistent with this, thymic CD3DH γδ T cells had 
reduced expression levels of the activation/ maturation markers 
CD122, CD44, CD73 and CD5. A detailed analysis of thymic γδ T 
cells throughout ontogeny revealed that Vγ6+ γδ17 T cells were de-
creased in early life but Vγ4+ γδ17 T cells developed normally, re-
sulting in normal γδ17 T cell abundance in the periphery of adult 
mice. In contrast, γδIFN T cells were diminished throughout life in 
the thymus and in peripheral lymphoid organs of CD3DH mice. Most 
importantly, CD122+ NK1.1+ γδIFN T cells (mostly Vγ1+) were virtu-
ally absent, but their thymic development could be rescued upon 
injection of an agonist CD3 antibody. The reduction in peripheral 
γδIFN T cells in CD3DH mice associated with less susceptibility to 
P berghei ANKA-driven experimental cerebral malaria, an inflamma-
tory syndrome dependent on IFNγ and γδ T cells.43,44
The CD3DH phenotype is surprising considering that single ha-
plodeficient mice did not show a similar impairment, and because 
several studies on TCR composition reported that CD3δ was not in-
corporated into the murine TCRγδ at least on mature γδ T cells.45,46 
Still, there might be a role of CD3δ subunit expression levels on 
TCRγδ assembly and expression during thymic development yet to 
be elucidated.
It is also intriguing that CD122+NK1.1+ γδIFN T cells appear to be 
especially dependent on TCRγδ signaling during development. It may 
be that these CD122+NK1.1+ γδ T cells represent a unique subset that 
has yet to be fully explored; we next summarize additional findings 
that support this possibility. In the thymus of adult wildtype mice, 
CD122+NK1.1+ γδ T cells are found among the CD44highCD24low ma-
ture γδ T cells (also termed “cluster B”).47 Cluster B in adult mice is 
made up of two mature γδ T cell subsets, the γδIFN NKT cells and 
the γδ17 T cells, both thought to represent resident cells originat-
ing from an early developmental wave. Indeed, about 50% express 
NK1.1, CD122 and CD27 and are strongly biased for Vγ1Vδ6.3 TCR 
expression, which identifies them as γδNKT cells of early ontogenic 
origin.38,47 It has been suggested that γδNKT cells undergo strong 
agonist selection during development, with endogenous ligand-me-
diated activation of the Vγ1Vδ6.3 TCR inducing promyelocytic leu-
kemia zinc finger (PLZF) expression and effector maturation of these 
cells.48,49 In the periphery, Vγ1Vδ6.3 γδNKT cells are most abundant 
in the liver. In the recent characterization of a conditional Bcl11b 
knockout mouse, two hepatic γδ T cell subsets with different de-
velopmental requirements were described: a NK1.1+CD5− subset 
generated early in newborn mice producing exclusively IFNγ rapidly 
upon infection; and a NK1.1−CD5+ subset that comprised both IFNγ 
and IL-17 producers.50 Interestingly, Bcl11b deficiency resulted in a 
complete loss of the NK1.1−CD5+ γδ T cell subset (besides a general 
block in αβ T cell development), whereas the NK1.1+CD5− proved to 
be Bcl11b-independent and retained CD122, high PLZF expression 
and IFNγ production upon stimulation. These observations suggest 
that the NK1.1+ γδIFN T cell subset has specific developmental prop-
erties and represents a unique innate-like population.
Another important clue on the role of TCR signaling in effector 
γδ T cell differentiation came from the analysis of Skint-1-deficient 
mice. Vγ5Vδ1 TCR-expressing DETC were shown to rely on encoun-
tering Skint-1 during development in the embryonic thymus to em-
bark on the IFNγ effector program. Absence of Skint-1 expression 
in a naturally occurring mutant strain resulted in Vγ5Vδ1 T cells that 
atypically produced IL-17 instead of IFNγ.51 The experiments sug-
gested that TCR ligation-induced signaling was the driving force to 
switch away from an intrinsic fetal γδ17 T cell fate.
A cell-intrinsic program indeed appears to drive the development 
of γδ17 T cells in the fetal/ perinatal thymus. Thus, IL-17 expression 
in early precursors prior to TCR rearrangement has been docu-
mented in the fetal thymus; and γδ17 T cells appear to require only 
weak or even no TCR signaling for their development.9,52 Moreover, 
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strong TCRγδ stimulation in fetal thymic organ culture (FTOC) dras-
tically reduced the generation of γδ17 T cells.20 It is worth to note 
that FTOC provide population-based endpoint analyses but do not 
allow following single thymocytes during development. Therefore, it 
cannot be ruled out that specific cells/ populations are lost from the 
pool rather than undergoing fate switching.
As a final point on TCR signaling, several studies have reported 
variable expression and dependency on associated proteins by dif-
ferent γδ T cell subsets. The main Src family kinase Lck was surpris-
ingly poorly expressed in mature γδ17 T cells in the thymus40 (and 
our unpublished observations), while Syk deficiency negatively im-
pacted especially on γδ17 T cells53; and Blk was required specifically 
for Vγ6+ γδ17 T cell development.54 These observations may also in-
dicate that there is more heterogeneity among developing γδ T cells 
(even at the signal transduction level) than initially expected.
3.2  |  γδ T cell progenitors – common or different 
for the effector subsets?
The identification of pre-programmed γδ T cell effector subsets and 
their key contributions to peripheral immune responses highlighted, 
once more, the importance of understanding thymic development. 
How γδ T cell effector subsets acquire their effector functions dur-
ing thymic development remains an area of active research and con-
troversies, particularly whether γδ17 and γδIFN T cells arise from 
common or distinct thymic progenitors.52,55 To understand the argu-
ment, we need to start at the αβ/γδ T cell bifurcation during early 
thymocyte development.
In the adult mouse, bipotential thymocytes were found up to the 
DN (double negative/CD4−CD8−) stage 2 (DN2), in which they si-
multaneously rearranged and transcribed Trb, Trg and Trd,47 whereas 
by the DN3 stage, the two lineages had fully diverged, as assessed 
through in vitro developmental potential assays.56,57 Two types of 
model have been proposed for the bifurcation of the αβ and γδ T 
cell lineages: pre-commitment and instructive models. A pre-com-
mitment model posits that a developing thymocyte is already set on 
its path/ fate when the TCR is expressed; and only cells that express 
a TCR concordant with its pre-determined fate (ie, pre-TCR for αβ 
T cells, and TCRγδ for γδ T cells) are able to develop further, while 
mismatched cells die off. On the other hand, an instructive model 
argues that the precursor is bipotential, and is directed into one or 
the other T cell lineage based on the TCR signals it receives, namely 
on the strength of such signals (reviewed in 58).
In support of pre-commitment, cell heterogeneity within the 
DN2 subset has been described and linked to different lineage bi-
ases prior to TCR expression. One notable example is the expression 
of the interleukin 7 receptor (IL-7R), since intrathymic injection and 
reconstitution of fetal thymic lobes with purified DN2 populations 
from adult mice demonstrated that the progeny of IL-7Rhigh DN2 
cells presented a higher γδ T cell to αβ T ratio compared to that of 
IL-7Rlow DN2 cells.59 Furthermore, IL-7R signaling has been clearly 
implicated in the regulation of gene rearrangement and transcription 
at the TCRγ locus,60-62 while it may play additional roles in promot-
ing the survival of γδ lineage cells.63,64 Similarly, SRY-related high 
mobility group box transcription factor 13 (Sox13) was identified 
as a putative γδ T cell-specific lineage regulator in the thymus.65 
Subsequent studies showed that Sox13 is required exclusively for 
thymic development of Vγ4+ γδ17 T cells, as these were absent in a 
spontaneous Sox13 mutant mouse strain, while other γδ T cell sub-
sets appeared to develop normally.66,67
On the other hand, TCR signal “strength” emerged as a key de-
terminant based on studies using transgenic TCRγδ expression, in 
which the manipulation of downstream signaling mediators had 
major effects on γδ vs αβ T cell commitment. In such settings, γδ T 
cells required stronger TCR signals to develop than their αβ T cell 
counterparts.68,69 It is noteworthy that besides full “knock-out” (KO) 
mice, also conditional KO strategies have been used to assess the 
role of signaling proteins during development and activation of T 
cells. Conditional KO strategies rely on introduction of a loxP site 
flanked version of the gene of interested and the expression of Cre 
recombinase from a specific promoter whose activity is restricted 
to a certain cell type or tissue. The heterogeneity within the γδ T 
cell lineage and our incomplete understanding of its developmental 
trajectories impose limitations to the use of several conditional KO 
mice for the analysis of γδ T cells. Indeed, conditional deletion using 
the proximal promoter of Lck-driven Cre (pLckCre) was shown to occur 
in DN2 cells and to efficiently target the αβ T cell lineage,70,71 but 
had complex effects on γδ T cells: while it failed to delete floxed 
genes in most adult-derived γδ T cells, it was significantly more effi-
cient (in mediating deletion) in γδ T cells generated during early life, 
including DETC, γδ17 T cells and γδNKT cells.72 These data further 
suggest that the developmental pathways of distinct γδ T cell sub-
sets may differ significantly.
An interesting possibility is the existence of various points of di-
vergence from the αβ T cell lineage path for discrete γδ T cell subsets. 
Support for such a “multiple branching-off model” first came from 
studies on E17 fetal thymi. While DN2 cells expressing high levels 
of c-kit developed into both IFNγ+ and IL-17+ γδ T cells, c-kitlow DN3 
cells failed to give rise to γδ17 T cells.73
More recently, a progenitor fate analysis and single-cell RNA 
sequencing of discrete DN1 subpopulations, as previously defined 
by Petrie and colleagues,74 suggested that Vγ4+ γδ17 T cells derive 
from CD44+CD25−CD24+c-Kit− (DN1d) but not DN2 precursors.52 
Such DN1d cells (from neonatal and young mice) contained a large 
proportion of Sox13-expressing cells, previously linked to Vγ4+ γδ17 
T cell development.66,75 Spidale et al showed that DN1d cells had a 
transcriptional profile similar to that of Vγ4+ γδ17 T cells, which was 
inferred to be TCR-independent from the analysis of mutant mice.52 
In the original analysis of DN1d cells by Petrie and colleagues, it 
had been noted their poor proliferative potential and faster differ-
entiation kinetics when compared to other DN1 and DN2 subsets. 
Moreover, the adult DN1d cell population contained no canonical T 
cell progenitors, showed B-cell potential in vitro, and was therefore 
dismissed from being an intermediate between the common lym-
phoid progenitor and DN2 thymocytes.74
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In contrast with the conclusions of Spidale et al,52 the earlier 
study by Shibata and colleagues reported that c-Kithigh DN2 cells can 
develop into γδ17 T cells.73 Of note, the two teams analyzed thymo-
cytes at different ages, which could explain the contradictory find-
ings. Shibata et al used purified E17 thymocytes and analyzed total 
γδ17 T cells, which contain many Vγ6+ cells, whereas Spidale et al em-
ployed DN1 and DN2 precursors from 10-day-old thymi, which were 
introduced into FTOC, and focused on Vγ4+ γδ17 T cell development. 
Since γδ17 T cell thymocyte development is supposed to be termi-
nated in 10-day-old mice,9 the question remains whether those DN1d 
progenitors are potential “leftovers” from the perinatal phase, which 
are “reset” for γδ17 T cell development upon transfer into the em-
bryonic (E15) thymic environment of the FTOC. Thus, it would be 
informative to gain experimental evidence from the late fetal/ peri-
natal phase on Vγ4+ γδ17 T cell development excluding a DN2 stage, 
while directly assessing the differences to earlier fetal Vγ6+ γδ17 T 
cell development.
In sum, there may be two separate waves of γδ T cell development 
that differ substantially with regard to thymic precursors and depen-
dence on TCR signaling. The first wave in the fetus is made up by a set 
of progenitor cells whose origin is not yet fully elucidated, but some 
reports suggest they may arise in the yolk sac.10,52 These fetal pro-
genitors are the first to develop in the thymus, an organ dynamically 
changing its composition and providing different microenvironments 
to developing T cells.76,77 Indeed, the first γδ T cells, expressing TCR 
Vγ chains that follow the timing of chromatin opening along the Tcrg 
locus, may develop into IL-17 producers by default, with no or low 
TCR signaling involved – unless the rearranged TCRs encounter their 
ligands, as it is the case for Vγ5Vδ1 DETC precursors, and potentially 
for Vγ1Vδ6 γδNKT cells. Ligand encounter does not seem to positively 
select the TCR repertoire, but instead divert the effector fate towards 
IFNγ production. Later on, a second wave of T cell progenitors enters 
the thymus; these differentiate towards γδIFN cells upon TCR signaling 
but are no longer prone to differentiate towards a default γδ17 fate, 
instead generating naïve, uncommitted γδ T cells that can display adap-
tive-like behavior in the periphery.41,76
Next, we will focus on the current view of the molecular mech-
anisms that underlie the acquisition and maintenance (or potential 
change) of γδ T cell effector functions.
4  |  γδ  T  CELL DIFFERENTIATION: FROM 
CHROMATIN TO POST-TR ANSCRIPTIONAL 
REGUL ATION
The acquisition of the capacity to secrete IFNγ and IL-17 during 
thymic development distinguishes γδ T cells from their αβ T helper 
cell counterparts, whose effector cell differentiation (Th1 or Th17, 
in this case) occurs in peripheral lymphoid organs upon activation 
in specific inflammatory milieus.78 Thus, it became important to 
decipher the molecular mechanisms of γδ T cell differentiation, and 
assess how similar or different they are from those previously estab-
lished for CD4+ T helper cells.
Some of the key questions addressed over the past decade have 
been:
1. How peripheral γδ T cell subsets expressing IFNγ or IL-17 
compare at the molecular level to their Th1 and Th17 coun-
terparts, respectively;
2. Whether the molecular determinants identified in peripheral γδ T 
cell subsets are imprinted during thymic development;
3. What are the relative contributions of epigenetic, transcriptional 
and post-transcriptional (including microRNA-based) mechanisms 
to the regulation of IFNγ and IL-17 expression in effector γδ T cell 
subsets.
In the next sections, we review the currently available data that 
provide some answers to these broad and still outstanding questions.
4.1  |  Epigenetic regulation of effector γδ T cell 
differentiation
Epigenetic mechanisms operating at the chromatin level control 
the maintenance of transcriptional networks ensuring autono-
mous maintenance of lineage phenotypes in differentiated cells, 
even through mitotic divisions.79 A very important of such epige-
netic mechanisms is based on histone modifications, which can ei-
ther associate with active gene expression or with gene repression. 
Thus, histone acetylation, H3K4 (lysine 4 of histone 3) methylation 
(H3K4me2 and H3K4me3) and H3K36me3 marks are associated 
with active transcription,80,81 whereas H3K27me3 and H3K9me3 
marks are deposited on silenced genes.81 Some of the first studies 
on genome-wide distribution of histone marks were actually per-
formed on T cells.81,82 By correlating histone modifications with 
gene expression profiles, such studies constituted the basis of our 
current understanding of the epigenetic (histone-based) landscape 
of active, repressed regions or “poised” genes. The latter, also called 
bivalent, show both active and repressive marks, mainly H3K4me2/
me3 and H3K27me3, respectively.83 This poised state enables si-
lenced genes to be rapidly induced under particular conditions, with 
gain of active histone marks and loss of repressive marks, therefore 
allowing developmental or functional plasticity. This is the case for 
CD4+ T helper cell subsets, where genes encoding transcription fac-
tors exhibit a large spectrum of epigenetic marks and allow for func-
tional plasticity.83
Recurring to CD27 levels to segregate IFNγ+ and IL-17+ γδ T cells, 
we isolated CD27+ (γδ27+) and CD27− (γδ27−) γδ T cells, respectively, 
from peripheral organs of C57BL/6 mice and subjected them to Chip-
seq (chromatin immunoprecipitation followed by deep sequencing) 
analysis of activating H3K4me2 and repressive H3K27me3 marks.84 
By comparing with Th1 and Th17 populations generated in vitro, we 
found that most of the genes differentially marked between γδ27+ 
vs γδ27− T cell subsets were not segregating between Th1 and Th17 
cells, suggesting that lineage-specific mechanisms operate in γδ T 
cell differentiation.83,84 An example was Dkk3, a modulator of Wnt 
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signaling with known regulatory functions in CD8+T cells,85 which 
displayed active H3K4me2 marks selectively in γδ27− T cells but not 
in γδ27+ T cells nor in either CD4+ helper T subset.84 Interestingly, 
Dkk3−/−γδ27− T cells were enriched for IL-17 producers when com-
pared with wildtype controls, although the underlying mechanism is 
yet to be clarified.
Our detailed analysis of chromatin marks in genes involved in 
global γδ T cell biology revealed that those implicated in γδ T cell de-
velopment (Bcl11b, Id3 or Etv5) and survival (Actb, Bcl2, Bcl2l1, B2m) 
displayed, as expected, very similar histone marking in γδ27+ and 
γδ27− T cells.84 However, the pattern of active vs repressive marking 
in genes implicated in the cytokine production programs was un-
expected. In particular, we were surprised to find that Ifnγ and its 
transcriptional regulators Tbx21, Eomes and Hlx, were all “primed” for 
expression in both γδ T cell subsets (Figure 3). By contrast, the pres-
ence of active histone modifications (H3K4me2 and H3 Acetylation) 
on Il17a and its key regulators, such as Rorc, Blk or Batf, as well as 
other type 17 signatures, like Ccr6, Il1r1 and Il23r, was clearly re-
stricted to γδ27− T cells. Consistent with this chromatin landscape, 
the transcript levels of Il17a were substantially different (>1000-fold) 
between the two subsets, whereas Ifng was only mildly (<10-fold) 
higher in γδ27+ cells compared to γδ27− cells. Importantly, the key 
epigenetic and transcriptional signatures observed in peripheral γδ 
T cell subsets were also present in their thymic counterparts,84 thus 
reinforcing the concept of developmental programming of effector 
γδ T cell subsets in the thymus.27,55
Building on these molecular analyses, we challenged the func-
tionalities of γδ T cell subsets in vitro and in vivo. We found that while 
γδ27+ cells do not produce IL-17, even under strong type 17-driving 
conditions, γδ27− T cells can co-express IFNγ (with IL-17) in highly 
inflammatory settings, ie, upon stimulation with high amounts of 
IL-1β and IL-23, or in an ovarian cancer microenvironment.84 These 
data suggested that in contrast to the “hard-wired” IFNγ producers 
within γδ27+ T cells, IL-17-producing γδ27− cells are endowed with 
functional plasticity, which can be deployed (to co-express IFNγ) 
under quite specific conditions. Subsequent work from our group 
showed that the polyfunctional γδ27− (γδ17) T cell population can 
also secrete IL-17F, IL-22 and GM-CSF upon IL-1β and IL-23 stimula-
tion,86 which is fully consistent with the permissive landscape of this 
subset.84 Likewise, within CD4+ T cells, Th17 cells are substantially 
more prone to plasticity than their Th1 or Th2 counterparts. Thus, 
Th17 cells are able to transdifferentiate into Th1, regulatory T (Treg) 
and follicular helper T (Tfh) cells,87 with chromatin-based mecha-
nisms, including bivalent marks in master regulators like Tbx21 or 
Gata3, also underlying their functional plasticity.83 Of note, Th17 cell 
plasticity is much more evident than that of γδ17 T cells. For exam-
ple, under the IL-23-rich inflammatory environment of experimental 
autoimmune encephalomyelitis (EAE), Th17 converted into Th1 cells, 
whereas γδ17 T cells remained “pure” IL-17 producers, ie they did 
not acquire IFNγ expression.88 This limited γδ T cell plasticity and its 
underlying mechanisms will be addressed at a later point (see 4.3.) 
in this review.
4.2  |  Transcriptional control of effector γδ T 
cell subsets
Following the genome-wide analysis of γδ T cell subsets,84 our group 
assessed the specific roles played by “master” transcription factors, 
like T-bet and RORγt, in controlling IFNγ and IL-17 production in 
these lymphocyte populations.
T-bet deficiency was found to significantly reduce IFNγ expres-
sion by peripheral γδ27+ T cells both in vitro and in vivo upon infec-
tion with murid herpes viruses, while also impairing IFNγ production 
by γδ27−CCR6+ T cells stimulated with IL-1β or IL-23 in vitro or during 
Listeria infection in vivo.86 By contrast, Eomes was not essential, 
since no differences in IFNγ expression were observed in Eomes−/− 
γδ27+ cells compared to controls,86 which confirmed T-bet as the 
main regulator of IFNγ expression by γδ T cells.89
On the other hand, RORγt (Rorc) deficiency completely abolished 
the production of IL-17 by γδ27− T cells.86 While in CD4+ T cells, IL-17 
production had been shown to be co-regulated by the auxiliary tran-
scription factors RORα and BATF,90 these factors were not required 
for IL-17 production by γδ T cells, since the corresponding mouse KO 
models displayed normal γδ17 T cell numbers.86 The same was true 
for IRF4, shown to be dispensable for IL-17 production by γδ T cells 
and other innate-like lymphocyte lineages.91
Of relevance, in γδ T cells, an additional and critical layer of 
TF-mediated regulation occurs during thymic development,92 and 
has been analysed in a global perspective by the Immgen consor-
tium, that performed gene expression profiling of thymic γδ T cell 
subsets.75 This genome-wide analysis identified three clusters of 
immature γδ T cells associated with distinct effector programs: the 
IL-17 producers (Vγ6+ and Vγ4+), the IFN-γ producers (Vγ1+, V7+) 
F I G U R E  3  Epigenetically “active” gene loci associated with γδ T 
cell effector functions. CD27−and CD27+γδ T cells, corresponding 
to IL-17+and IFNγ+γδ T cell subsets, respectively, display active 
dimethylated H3K4me2 marks in loci of genes associated with their 
effector functions (from the Chip-Seq analysis in84). Loci of genes 
associated with IL-17 production (blue) are only actively marked in 
CD27−T cells, whereas loci of genes related with IFNγ production 
(red) are actively marked in both subsets, highlighting the potential 
of IL-17+γδ T cells to engage in both cytokine programs
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and DETCs (Vγ5+), with Rorc, Maf, Sox13, and Sox4 associated with 
the IL-17A producers; and Tcf7 (TCF-1), Lef1, Tbx21 (T-bet) and 
Eomes with the IFNγ producers. These results were confirmed in 
additional studies that showed, for example, that Sox13, Sox4, and 
the Ets family member ETV5, are key regulators of the development 
of γδ17 T cells.66,67 Additionally, Hes-1, a component of the Notch-
signaling pathway, and RelB, a member of NF-κB family, promote 
IL-17 production by γδ thymocytes,93,94 while ID3 antagonizes this 
program by binding to HEB, an E protein TF required for expression 
of Sox13 and Sox4.95 Of note, although Eomes expression levels 
are consistently higher in γδIFN compared to γδ17 cells, this TF is 
not essential for γδIFN cell differentiation,86 as mentioned above.
A recent study has added an important temporal dimension 
to the role of some of these transcription factors regulating thy-
mic γδ17 cell differentiation. Upon performing single-cell analyses 
of Sox13, Maf and Rorc knockout mice, Sagar and colleagues have 
shown a sequential activation of these factors during both fetal and 
adult γδ17 cell differentiation.96 More specifically, Sox13-deficient 
mice lacked Maf+ Rorc+ Il17a+ Il17f+ γδ T cells in the fetal thymus, and 
displayed reduced levels of Maf, Blk and Roc in γδ T cells from adult 
thymus, whereas Maf-deficient fetal thymi lacked Rorc+ Il17a+ γδ T 
cells, and Rorc-deleted γδ T cells did not show reduced Sox13 or Maf 
expression. Thus, during thymic γδ17 cell development, Sox13 acts 
upstream of c-MAF which is essential for RORγt function in orches-
trating the γδ17 program.96
A more detailed discussion on the transcriptional networks oper-
ating in effector γδ T cell subsets, especially during thymic pre-pro-
gramming, is provided by Anderson and colleagues elsewhere in this 
issue. Of note, an important regulatory function of TFs is to act as 
chromatin remodelers, mostly as promoters of open chromatin, thus 
leaving specific T cell loci accessible to other TFs/regulatory factors. 
Although, so far, no studies have specifically addressed this issue in 
γδ T cells, several TFs have been implicated in chromatin remodelling 
during CD4+ T helper cell differentiation. This is the case for BATF 
and IRF4, which promote opening of chromatin at Th17 cell-specific 
loci, allowing access to RORγt.90 Also, members of the STAT family of 
TFs were shown to shape the landscape of Th1, Th2 and Th17 cells, 
with STAT1 and STAT4 inducing T-bet, which then acts in conjunc-
tion with Eomes, Hlx, and Runx to induce Th1 cell differentiation, 
while STAT3 promotes Th17 cell differentiation.83,97,98 Although the 
role of STAT1 and STAT4 in the differentiation of IFNγ+ γδ T cells has 
not been addressed, STAT3 was shown to be dispensable for the 
generation of IL-17-producing γδ T cells.93 Therefore, the relevance 
of this layer of regulation (chromatin remodeling) for effector γδ T 
cell differentiation remains unclear.
Other issues that require further elucidation are (i) which ex-
tracellular cues, including potential TCR ligands, may feed in and 
regulate the transcriptional programs required for effector γδ T cell 
differentiation; and (ii) how the transcriptional networks described 
separately for thymic and peripheral γδ T cells are integrated, and 
potentially cross-talk, within the cell. Future studies, based on sin-
gle-cell analysis, will likely contribute to improving our understand-
ing of these phenomena.
4.3  |  Post-transcriptional regulation of γδ T 
cell plasticity
Our group has been recently addressing the role of non-coding 
RNAs, with special attention to microRNAs, in effector γδ T cell 
differentiation.
MicroRNAs (miRNAs) constitute a fundamental layer of 
post-transcriptional regulation, acting as negative regulators of ex-
pression for most mammalian genes by promoting the degradation 
of mRNAs or preventing their translation.99 The overall relevance 
of miRNAs for immune cell functions has been demonstrated upon 
specific depletion of key enzymes involved in the biogenesis of miR-
NAs in early stages of immune cell differentiation. Namely, ablation 
of all mature miRNAs at early stages of thymocyte development via 
genetic deletion of Dicer or Drosha, two crucial enzymes in miRNA 
biogenesis,100 results in a developmental block that reduces num-
bers of peripheral mature αβ T and invariant natural killer T (iNKT) 
cells. Moreover, CD4+ T cells show reduced proliferation and sur-
vival after in vitro stimulation, but increased frequencies of IFNγ 
producers, implicating miRNAs in T helper cell differentiation.101-103 
Furthermore, the absence of microRNAs in naïve T cells hinders the 
development and function of regulatory T cells (Tregs), thus disrupt-
ing the balance between effector and regulatory T cells, breaking 
tolerance and causing immune pathology in vivo.101,103,104
Interestingly, the development of γδ T cells is not impaired by 
miRNA ablation; on the contrary, there is a substantial increase of 
γδ T cells in the double negative thymic compartment of mice con-
ditionally lacking Dicer in early thymocytes.105 However, only a very 
limited number of studies have addressed the role of miRNAs in γδ 
T cell differentiation. miR-133b and miR-206 were the first miRNAs 
shown to be co-regulated with IL-17 in both γδ and αβ T cells, but had 
no functional impact on cytokine production.106 In another study, 
based on the fact that miR-181a/b-1 cluster is highly expressed 
during thymocyte development and positively regulates TCR signal 
strength,107,108 Prinz and co-workers assessed its role in γδ T cells, 
but found miR-181a/b-1 deficiency to have no impact on thymic γδ T 
cell numbers or differentiation towards and IL-17- or IFNγ-producing 
effectors.109
More recently, our group identified miR-146a as functionally rel-
evant for γδ T cell differentiation, and an important determinant of 
the limited functional plasticity of γδ27− cells (Figure 4). Based on mi-
croarray analysis, we identified 35 miRNAs differentially expressed 
between γδ27+ and γδ27− T cells from peripheral organs.110 MiR-
146a and miR-146b were both upregulated in γδ27− cells, but the 
later showed very low abundance in all T cell subsets analysed, and 
was therefore not studied further. MiR-146a had previously been 
shown to exert anti-inflammatory functions, including via regulation 
of the IFNγ program in both CD4+ and CD8+T cells.111 Consistent 
with the profile observed in peripheral γδ T cells, miR-146a displayed 
markedly increased expression levels as thymic precursors matured 
into γδ27− thymocytes.110 Interestingly, miR-146a expression could 
not be modulated neither by exogenous TCR stimulation nor inflam-
matory cytokines, thus suggesting a tight control by endogenous 
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thymic signals. Functional overexpression studies showed that miR-
146a down-regulates IFNγ production in γδ27+ T cells. Conversely, 
in the miR-146a KO mouse model,111 a cell-intrinsic increased fre-
quency of double-producing IL-17+ IFNγ+ cells was observed among 
γδ27− T cells in vitro (stimulated with IL-1β and IL-23) and in vivo, 
upon Listeria monocytogenes infection.110
A differential Argonaute-2 (Ago2) RIP-seq strategy allowed us to 
identify Nod1 as a novel target of miR-146a in γδ T cells,110 distinct 
from the conventional miR-146a targets (Traf6, Irak1, and Stat1, 
among others) identified in other immune cells such macrophages, B 
cells and αβ T cells,111-116 thus highlighting lineage-specific roles for 
miRNAs based on the potential target transcripts that are present. 
We found Nod1 expression levels to be consistently lower in γδ27-T 
cells (and Vγ1−Vγ4−/Vγ6+ γδ T cells) compared to γδ27+T cells, in ac-
cordance with the expected inverse correlation between the levels 
of a given miRNA and its target mRNA. In fact, the high expression of 
Nod1 in γδ27+ T cells is consistent with Nod1-mediated promotion of 
IFNγ production in CD4+ and CD8+ T cells, given that Nod1-deficient 
αβ T cells have impaired IFNγ responses in vivo.117 Furthermore, we 
found that Nod1−/− γδ27− cells were unable to differentiate into IL-17+ 
IFNγ+ double producers, in opposition to the phenotype (accumula-
tion of IL-17+ IFNγ+ cells) of miR-146a−/− γδ27− cells (all compared 
to WT controls).110 Moreover, by performing a genetic rescue ex-
periment upon crossing miR-146a−/− with Nod1−/− mice (analyzing 
littermate controls) revealed that heterozygous Nod1 reduction (in 
miR-146−/− Nod1+/− mice) prevented the accumulation of double pro-
ducers among γδ27− T cells observed in miR-146−/− Nod1+/+ mice. 
These results collectively indicate that Nod1 is the key miR-146a 
target implicated in the regulation of γδ27− cell plasticity. Of note, 
until now, only one other miRNA has been implicated in T helper 
cell plasticity, miR-10a, which restricts regulatory CD4+ T cells from 
acquiring Th17 and follicular helper T cell characteristics.118
In sum, we have shown that miR-146a limits γδ T cell plasticity by 
targeting Nod1, an intracellular pattern recognition receptor that is 
an important mediator of endoplasmic reticulum (ER) stress-induced 
production of pro-inflammatory cytokines,119 although the specific 
mechanism of action in γδ T cells remains to be elucidated. Beyond 
miR-146a, our group is committed to characterize other relevant 
miRNAs, and even the full miRNome of effector γδ T cell subsets.
4.4  |  Extracellular signals that control peripheral 
effector γδ T cell subsets
Peripheral effector γδ T cell responses rely either on the activation 
and expansion of thymically (fetally/ perinatally) pre-programmed 
cells; or on activation and de novo differentiation of effectors from 
naïve γδ T cells exported from the adult thymus.120 While, barring a 
few exceptions,34 antigen-specific γδ T cell responses remain illusive 
(as does the molecular identity of most TCRγδ ligands), various ex-
tracellular signals conveyed by co-receptors and cytokine receptors 
have been implicated in controlling the peripheral pools of effector 
γδ T cell subsets.
Our group has shown that the CD70−CD27 pathway, besides critical 
during γδ thymocyte development,28 selectively promotes peripheral 
IFNγ+ γδ T cell responses via expansion of γδ27+ cells.121 CD27 signal-
ling, which synergizes with TCR signals via non-canonical NF-κB, is re-
quired for survival and proliferation of γδ27+ cells, thus controlling their 
F I G U R E  4  Regulation of IL-17 and IFNγ expression in γδ T cell subsets. Integration of different levels of gene expression in CD27−(IL-17+) 
and CD27+(IFNγ+) γδ T cell subsets. CD27+IFNγ-producing γδ T cells display active marks (H3K4me2) exclusively in IFNγ and related 
transcription factor loci, while the IL-17 locus is repressed (as dictated by repressive H3K27me3 marks). By contrast, CD27−IL-17-producing 
γδ T cells display active chromatin marks (H3K4me2) in both IL-17 and IFNγ gene loci, as well as their respective transcriptional regulators 
RORγt and T-bet, which drive IL-17 and IFNγ mRNA expression, respectively. However, co-production of IL-17 and IFNγ is only observed 
under limited and strongly inflammatory conditions. In the steady state, CD27−IL-17-producing γδ T cells express high levels of miR-146a, 
which acts as a brake for IFNγ production by inhibiting the expression of Nod1, an inducer of IFNγ production in γδ T cells
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responses to viral and parasitic infections in vivo.121 CD28 is another 
co-receptor that supports TCR signalling in promoting γδ T cell survival 
and proliferation, in this case via induction of IL-2 production.122,123 
This is seemingly important for both γδIFN and γδ17 cells, since CD28-
deficient mice failed to expand both subsets upon Plasmodium berghei in-
fection, which contrasted with the γδIFN-specific effect of CD27.121-123
Other “costimulatory” (or inhibitory) receptors reported to 
differentially impact on γδIFN and γδ17 T cells are CD137, CD30, 
BTLA and PD-1. Agonist anti-CD137 (4-1BB) antibodies promoted 
the expansion of IFNγ+ Vγ1+ T cells, which protected mice from 
Listeria infection in an IFNγ-dependent manner.124 On the other 
hand, CD30-deficient mice displayed a selective depletion of IL-17+ 
Vγ6+ T cells in mucosal tissues in the steady-state and upon Listeria 
infection, which associated with reduced bacterial clearance, and 
could be rescued upon administration of an agonist anti-CD30 an-
tibody.125 As for BTLA and PD-1, they were shown to be important 
negative regulators of dermal γδ17 cells, with major pathophysio-
logical impacted on psoriatic-like skin inflammation.126,127
Another important molecular layer of γδ T cell activation and 
differentiation are cytokines, including usual suspects like IL-2122 or 
IL-7,128 but especially the innate cytokines IL-1β and IL-23, which are 
pivotal for γδ 17 T cells. Indeed, stimulation with IL-1β and IL-23, but 
not TGF-β or IL-6, is sufficient to trigger abundant IL-17 secretion by 
γδ27− cells in vitro, even in the absence of TCR stimulation.86,129,130 
This “innate” mode of γδ17 T cell activation is underlined by their 
rapid response to pathogen-associated molecular patterns like 
lipopolysaccharide or lipoproteins, ligands for TLR4 and TLR2, 
respectively, via myeloid cells producing the key IL-1β and IL-23 cyto-
kines.121 Notably, IL-1β and IL-23 are also the main inducers of γδ17 
T cell plasticity, ie the co-expression of IFNγ with IL-17 in γδ27− T 
cells,84,86 as discussed above.
Finally, IL-1β and especially IL-23 can also drive de novo differ-
entiation of γδ17 cells from naïve peripheral γδ T cells. While the ac-
quisition of the IL-17-producing capacity of “natural” or thymic γδ17 
T cells occurs exclusively during fetal/ perinatal development,26 re-
lying on fetal progenitors9 and fetal thymic microenvironment,131 
inflammatory IL-1β and IL-23 signals were found to induce the differ-
entiation of peripheral γδ17 T cells from adult bone marrow-derived 
naïve precursors.132,133 This was shown not only in vitro but also in 
animal models or multiple sclerosis 130 and psoriasis.133 More re-
cently, Zarin et al demonstrated that IL-1β and IL-23 also supported 
differentiation of γδ17 T cells in an in vitro OP9-DL4 co-culture sys-
tem and in FTOC, suggesting an unanticipated role for these inflam-
matory cytokines during thymic development.134,135
5  |  OPEN QUESTIONS AND 
PERSPEC TIVES
This review focused on several layers of regulation of mouse ef-
fector γδ T cell differentiation, while highlighting our group's main 
contributions. Despite the significant progress made over the past 
decade, various issues remain incompletely understood.
The signals involved in dictating effector cell commitment con-
tinue to be an area of intensive research, now benefiting from full 
transcriptomic comparisons and pseudotime alignments of single thy-
mocytes through the use of single-cell RNA sequencing approaches. 
These may allow the dissection of novel TCR-dependent vs indepen-
dent thymic γδ T cell developmental pathways, as well as resolve the 
contradiction of having low or no TCR signalling in γδ17 T cell devel-
opment within a γδ T cell lineage promoted (at the αβ/γδ bifurcation) 
by strong TCR signals. Moreover, such single-cell approaches will 
permit further validation of the proposed model suggesting that γδ17 
and γδIFN T cells arise from distinct thymic progenitors.52,55
Besides the TCR, for which the identification of bona fide ligands 
remains a priority,136 it will be important to clarify which other mo-
lecular cues determine effector γδ T cell commitment, especially for 
γδ17 T cells for which TCR signals seem irrelevant (or even coun-
terproductive.20 Recent evidence suggest that Notch signaling pro-
motes γδ17 T cell development,134,135 but it would be important 
to clarify the role of other major signaling axis, such as Wnt and 
Hedgehog.137 Ongoing studies to dissect the transcriptome and pro-
teome of single thymocytes at different developmental stages will 
help to gain more insight into the trajectories and decision-making 
during development of the heterogeneous γδ T cell lineage, taking 
into account ontogenic timing, distinct progenitor pools and the 
highly dynamic thymic microenvironment.
Following the seminal research performed on the basis of surface 
markers or TCR Vγ chain usage, we believe future studies should em-
ploy cytokine reporter mice to isolate pure populations of IL-17- or 
IFNγ-expressing cells, so that cellular and molecular properties can 
be directly associated to effector functions (within heterogeneous 
γδ T cell subsets). We have generated mice with reporter gene mark-
ers for both cytokines (il17a-GFP Ifng-YFP), which we are using to 
define the full mRNA and miRNA transcriptomes of “pure” effector 
γδ T cell subsets. By combining with single-cell technologies it will be 
possible to enquire the potential heterogeneity even within IL-17- or 
IFNγ-expressing populations.
Another critical aspect will be how to best assess the function 
of particular genes within the γδ T cell lineage. Indeed, a major 
limitation of our (and other group's) studies so far is the analysis of 
γδ T cell phenotypes in full KO animals, rather than having specific 
gene ablation in γδ T cells. Although some promoters, such as Lck 
or Cd4, have been used to delete genes in the T cell compartment, 
in what refers to γδ T cells, the conditional KO strategy that en-
sures the most efficient deletion of genes is based on the use of 
Vav1 promoter-driven Cre (Vav1Cre).72 Thus, future studies should 
use this strategy to test gene requirements within the γδ T cell 
lineage. Ideally, one would use a highly penetrant lineage-specific 
promoter, but that quest has turned out very difficult, with even 
Tcrd-Cre showing limitations to delete genes in most γδ T cell pop-
ulations (except DETC).138
Upcoming research should further elucidate the extracellular 
signals that drive peripheral effector γδ T cell responses. A current 
view that requires more experimental support is that γδ17 cells 
respond to innate signals, whereas γδIFN cells may be involved in 
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adaptive-like responses, including antigen specificity (for which, 
again, the identification of TCRγδ ligands remains critical). This is an 
outstanding topic also in human γδ T cell biology.139 On the other 
hand, with γδ17 cells being found to play important roles in steady-
state tissue physiology,8,140-143 the signals that regulate their activi-
ties in situ are now also a notable unresolved question.
Finally, while this review was focused on IL-17 and IFNγ pro-
duction as hallmark effector functions of murine γδ T cells, one 
should highlight their versatility in mice and humans: besides 
being highly cytotoxic, as acknowledged for decades and cur-
rently being explored for cancer immunotherapy,144,145 γδ T cells 
can provide a pleiotropy of factors, from antimicrobial peptides 
146 to wound healing associated cytokines like amphiregulin.147 
Therefore, we believe the modulation of γδ T cell activities will 
hold promise in multiple settings of infection and inflammation-as-
sociated diseases.
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